Hepatitis C
-
Gilead shoves off Roche’s claim on Sovaldi hep C drug
-
Sovaldi hepatitis C drug at $84,000 per treatment course sparks healthcare concerns
-
Hepatitis C will be rare disease in 2036, experts predict
-
Despite cost, $1,000 hepatitis C pill is now leading treatment
-
Sovaldi helps treat hepatitis C virus in HIV patients too
-
Study shows promising hep C cure for patients co-infected with HIV
-
Senate Committee asks Gilead why Hepatitis C drug Sovaldi costs $1000 a pill
-
U.S. Senate probes pricing of Hepatitis C drug Sovaldi
-
Senate asks Gilead Sciences to explain itself, high cost of Hep C drug
-
Egyptian military's 'complete cure device' for AIDS, hepatitis C needs more testing
-
FDA approves AbbVie's hepatitis C regimen for priority review
-
New hepatitis C treatment very effective: Over 90 percent success rate in patients with cirrhosis
Most Popular
